Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07206979 · ClinicalTrials.gov registry record · NA
An Open Label Trial Assessing the Impact of a Hydration Formula on Overall Health
A NA study, sponsored by Radicle Science.
- Not yet
- Registry status
- NA
- Development phase
- 660
- Enrollment target
NCT07206979: Clinical Trial NA study, sponsored by Radicle Science.
NCT07206979 is a NA study that has not yet begun recruiting, run by Radicle Science. The registered enrollment target is 660 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07206979, a NA study, has not yet begun recruiting, sponsored by Radicle Science.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 660 participants
- Enrollment target
Study Summary
An Open Label Trial Assessing the Impact of a Hydration Formula on Overall Health
Primary Outcome
Hydration; Differences in self-reported perceptions of hydration as assessed by an item assessing perceptions of hydration (scale 1-5; where higher scores correspond to greater feelings of hydration)
Interventions
- DIETARY_SUPPLEMENT Hydration Active Product 1
- DIETARY_SUPPLEMENT Hydration Active Product 2
- DIETARY_SUPPLEMENT Hydration Active Product 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 660 participants |
| Start Date | 2025-09-30 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What is known before NCT07206979 opens enrollment
NCT07206979 is an interventional study that assigns participants to a tested intervention. The registered 660 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 3 interventions - of which Hydration Active Product 1 is the first listed.
NCT07206979 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07206979 about?
NCT07206979 is a clinical study titled "An Open Label Trial Assessing the Impact of a Hydration Formula on Overall Health". An Open Label Trial Assessing the Impact of a Hydration Formula on Overall Health
What is the current status of trial NCT07206979?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 660 participants. The study started on 2025-09-30. Estimated completion is 2026-09-30.
What interventions are being tested in trial NCT07206979?
The interventions under investigation include: Hydration Active Product 1 (DIETARY_SUPPLEMENT), Hydration Active Product 2 (DIETARY_SUPPLEMENT), Hydration Active Product 3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07206979?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07206979's enrollment target sits among peer trials
660 155th of 2000 higher than 1,845 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
- NCT03346694 · 660 participants · NA
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
- NCT05407636 · 660 participants · Phase 3
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
- NCT05470205 · 660 participants · Phase 3
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI